Literature DB >> 11289047

Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.

J He1, S Watkins, D E Kelley.   

Abstract

In obesity and type 2 diabetes, skeletal muscle has been observed to have a reduced oxidative enzyme activity, increased glycolytic activity, and increased lipid content. These metabolic characteristics are related to insulin resistance of skeletal muscle and are factors potentially related to muscle fiber type. The current study was undertaken to examine the interactions of muscle fiber type in relation to oxidative enzyme activity, glycolytic enzyme activity, and muscle lipid content in obese and type 2 diabetic subjects compared with lean healthy volunteers. The method of single-fiber analysis was used on vastus lateralis muscle obtained by percutaneous biopsy from 22 lean, 20 obese, and 20 type 2 diabetic subjects (ages 35+/-1, 42+/-2, and 52+/-2 years, respectively), with values for BMI that were similar in obese and diabetic subjects (23.7+/-0.7, 33.2+/-0.8, and 31.8+/-0.8 kg/m2, respectively). Oxidative enzyme activity followed the order of type I > type IIa > type IIb, but within each fiber type, skeletal muscle from obese and type 2 diabetic subjects had lower oxidative enzyme activity than muscle from lean subjects (P < 0.01). Muscle lipid content followed a similar pattern in relation to fiber type, and within each fiber type, muscle from obese and type 2 diabetic subjects had greater lipid content (P < 0.01). In summary, based on single-fiber analysis, skeletal muscle in obese and type 2 diabetic subjects mani-fests disturbances of oxidative enzyme activity and increased lipid content that are independent of the effect of fiber type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289047     DOI: 10.2337/diabetes.50.4.817

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  139 in total

Review 1.  Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

2.  Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects.

Authors:  E E Blaak; S L Schiffelers; W H Saris; M Mensink; M E Kooi
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

Review 3.  The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans.

Authors:  Martin Krssak; Michael Roden
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 4.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

5.  Fibre type-specific satellite cell response to aerobic training in sedentary adults.

Authors:  Christopher S Fry; Brian Noehren; Jyothi Mula; Margo F Ubele; Philip M Westgate; Philip A Kern; Charlotte A Peterson
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

6.  Mitochondrial succinate dehydrogenase is involved in stimulus-secretion coupling and endogenous ROS formation in murine beta cells.

Authors:  Armin Edalat; Philipp Schulte-Mecklenbeck; Cita Bauer; Sabrina Undank; Peter Krippeit-Drews; Gisela Drews; Martina Düfer
Journal:  Diabetologia       Date:  2015-04-15       Impact factor: 10.122

7.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

8.  Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Ricardo Azziz
Journal:  Hum Reprod       Date:  2014-05-09       Impact factor: 6.918

9.  Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.

Authors:  G Lattuada; F Costantino; A Caumo; P Scifo; F Ragogna; F De Cobelli; A Del Maschio; L Luzi; G Perseghin
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

10.  Pknox1/Prep1 regulates mitochondrial oxidative phosphorylation components in skeletal muscle.

Authors:  Timo Kanzleiter; Michaela Rath; Dmitry Penkov; Dmytro Puchkov; Nadja Schulz; Francesco Blasi; Annette Schürmann
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.